149 related articles for article (PubMed ID: 34551570)
21. Efficacy and prognosis analyses of apatinib combined with S-1 in third-line chemotherapy for advanced gastric cancer.
Wu Q; Fu Y; Wen W; Xi T; Zhao G
J BUON; 2020; 25(2):987-994. PubMed ID: 32521896
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety assessment of apatinib in patients with advanced gastric cancer: a meta-analysis.
Chen J; Wang J
Onco Targets Ther; 2018; 11():4149-4158. PubMed ID: 30050306
[TBL] [Abstract][Full Text] [Related]
23. Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression.
Wang Z; Huang Y; Long L; Zhou L; Huang Y; Gan L; Pu A; Li S; Xie R
J Ovarian Res; 2021 Jul; 14(1):91. PubMed ID: 34247630
[TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma.
Zhao J; Lei J; Yu J; Zhang C; Song X; Zhang N; Wang Y; Zhang S
Invest New Drugs; 2020 Apr; 38(2):500-506. PubMed ID: 31650447
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients.
Huang D; He Q; Zhai L; Shen J; Jing F; Chen H; Zhu X; Zhou J
Front Pharmacol; 2022; 13():843905. PubMed ID: 36034824
[No Abstract] [Full Text] [Related]
26. Association of Apatinib and Breast Cancer: A systematic review and meta-analysis.
Wang H; Su W; Lowe S; Zhou Z; Bentley R; Zhou Q; Cheng C; Guo X; Song Q; Liang Q; Li N; Liang M; Zhu Y; Sun C
Surg Oncol; 2022 Sep; 44():101818. PubMed ID: 35930900
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC.
Wu D; Liang L; Nie L; Nie J; Dai L; Hu W; Zhang J; Chen X; Han J; Ma X; Tian G; Han S; Long J; Wang Y; Zhang Z; Xin T; Fang J
Asia Pac J Clin Oncol; 2018 Dec; 14(6):446-452. PubMed ID: 29573236
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of
Wang X; Wang H; Cao L; Wu J; Lu T; Li S; Li J
Front Nutr; 2021; 8():784164. PubMed ID: 34957186
[No Abstract] [Full Text] [Related]
29. Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.
Wu YS; Shui L; Shen D; Chen X
Oncotarget; 2017 Feb; 8(6):10703-10713. PubMed ID: 27793044
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of apatinib plus chemotherapy vs. chemotherapy alone for the treatment of advanced‑stage non‑small cell lung cancer: A meta‑analysis.
Qin S; Han X; Li Z
Oncol Lett; 2024 Jan; 27(1):25. PubMed ID: 38073772
[TBL] [Abstract][Full Text] [Related]
31. [Intercalated Combination of Chemotherapy and EGFR-TKIs versus Chemotherapy Alone in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis].
Hong C; Mei T; Wang J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):837-846. PubMed ID: 27978869
[TBL] [Abstract][Full Text] [Related]
32. Apatinib in the treatment of advanced non-small-cell lung cancer: A meta-analysis.
Yu GC; Yang J; Ye B; Xu LL; Li XY; Zheng GR
Math Biosci Eng; 2019 Aug; 16(6):7659-7670. PubMed ID: 31698632
[No Abstract] [Full Text] [Related]
33. Kangai Injection Combined with Platinum-based Chemotherapy for the Treatment of Stage III/IV Non-Small Cell Lung Cancer: A Meta-analysis and Systematic Review of 35 Randomized Controlled Trials.
Li H; Ji Y; Zhang S; Gao Z; Hu C; Jiang R; Chen M; Li G; Zhang X
J Cancer; 2019; 10(21):5283-5298. PubMed ID: 31602279
[No Abstract] [Full Text] [Related]
34. A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients.
Yang M; Liu X; Zhang C; Liao F; Li Z; Luo X; Sun Y; Chen C
Cancer Manag Res; 2019; 11():8869-8876. PubMed ID: 31632146
[TBL] [Abstract][Full Text] [Related]
35. Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases.
Xu J; Liu X; Yang S; Shi Y
Oncol Res; 2020 Mar; 28(2):127-133. PubMed ID: 31610827
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of anti-epidermal growth factor receptor agents for the treatment of oesophageal cancer: a systematic review and meta-analysis.
Zhang L; Song Y; Jiang N; Huang Y; Dong B; Li W; He Y; Chen Y; Liu H; Yu R
BMJ Open; 2021 Mar; 11(3):e046352. PubMed ID: 33753446
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis.
Xue JM; Astère M; Zhong MX; Lin H; Shen J; Zhu YX
Onco Targets Ther; 2018; 11():6119-6128. PubMed ID: 30288047
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis.
Sun D; Hou H; Zhang C; Zhang X
Onco Targets Ther; 2018; 11():6539-6554. PubMed ID: 30323627
[TBL] [Abstract][Full Text] [Related]
40. [Systematic evaluation and Meta-analysis of Xiao'er Chaigui Tuire Granules in treating hand, foot and mouth disease].
Nie WY; Lyu J; Xie YM; Sun MH
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3539-3546. PubMed ID: 32893542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
